Clinical trial
Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients
NCT00379418 · Emory University, Other · Completed
Key facts
| NCT number | NCT00379418 |
|---|---|
| Title | Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients |
| Official title | Anti Ischemic Effects of Abciximab in Angioplasty and Stenting Patients (AIR) |
| Acronym | AIR |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Coronary Artery Disease |
| Intervention type | Drug |
| Interventions | Abciximab |
| Enrollment | 220 |
| Start date | Jan 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 21, 2006 |
| Last update posted | Sep 12, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: